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ABSTRACT
The posterior cingulate cortex (PCC) and corpus callosum (CC) are susceptible to trauma, but injury often
evades detection. PCC Metabolic disruption may predict CC white matter tract injury and the secondary
cascade responsible for progression. While the time frame for the secondary cascade remains unclear in
humans, the first 24 h (hyper-acute phase) are crucial for life-saving interventions.
Objectives: To test whether Magnetic Resonance Imaging (MRI) markers are detectable in the hyper-
acute phase and progress after traumatic brain injury (TBI) and whether alterations in these parameters
reflect injury severity.
Methods: Spectroscopic and diffusion-weighted MRI data were collected in 18 patients with TBI (within
24 h and repeated 7–15 days following injury) and 18 healthy controls (scanned once).
Results: Within 24 h of TBI N-acetylaspartate was reduced (F = 11.43, p = 0.002) and choline increased (F =
10.67, p = 0.003), the latter driven by moderate-severe injury (F = 5.54, p = 0.03). Alterations in fractional
anisotropy (FA) and axial diffusivity (AD) progressed between the two time-points in the splenium of the CC
(p = 0.029 and p = 0.013). Gradual reductions in FA correlated with progressive increases in choline (p =
0.029).
Conclusions: Metabolic disruption and structural injury can be detected within hours of trauma.
Metabolic and diffusion parameters allow identification of severity and provide evidence of injury
progression.
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Introduction
Traumatic brain injury (TBI) is a leading cause of mortality
and morbidity worldwide. Gaps in our knowledge regarding
the pathophysiology of the secondary injury cascade in the
first few hours following trauma limit our ability to accurately
classify patients and optimize treatment. Biochemical and
metabolic markers that reflect the broad pathophysiological
heterogeneity and injury progression following TBI could
potentially guide clinical decisions regarding hospital admis-
sion, escalation of care and therapeutic interventions in the
hyper-acute phase (<24 h) following trauma.
Studies investigating all severities of injury following TBI
highlight a crucial link between diffuse axonal injury (DAI)
and patients’ long-term clinical outcome and persistent defi-
cits (1–3). DAI results from rapid acceleration/deceleration of
the head, causing stretch and shear injuries to axons and
blood vessels. The viscoelastic nature of white matter axons
makes them particularly susceptible to damage (4,5). Axonal
injury results not just from the initial mechanical insult (pri-
mary injury) but due to a progressive molecular and cellular
cascade of pathologic changes within the axon after the initial
stress (4,5) causing secondary injury detectable using DTI in
a lateral fluid percussion (LFP) model in rats (6).
DAI is now considered a process influencing multiple
disparate brain regions (7). The secondary injury cascade is
thought to be responsible for the progression of DAI with
membrane disruption, excitotoxicity, inflammation and neu-
ronal injury affecting the evolution of axonal pathology
(3,8,9). Despite attempts using LFP models in rats to better
understand the secondary cascade in white matter tracts ques-
tions remain regarding the microstructural disturbance that
occurs after trauma (6). MRI techniques, and in particular
Magnetic Resonance Spectroscopy (MRS), have identified
clinically relevant injury patterns in the first few days after
trauma (10,11). Specific metabolites provide information
regarding separable pathophysiological processes occurring
in the primary and secondary injury phases following TBI
(12). Decreased N-acetylaspartate (NAA), a marker of neuro-
nal density and viability, and increased choline (Cho),
a marker of membrane synthesis and gliosis have been
demonstrated in the acute phase (days) (13). Additionally,
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early excitotoxic injury (within 7 days) has been indicated by
elevated glutamate/glutamine (Glx) in white matter (14),
which conversely, may be reduced in the gray matter follow-
ing TBI (15,16).
MRS evidence of diffuse injury in TBI has been hypothe-
sized to reflect differential processes across injury severities
(17–19). Kirov hypothesized that mild, as well as severe TBI,
can result in DAI with cell dysfunction resulting from mild
injury and cell death and Wallerian degeneration resulting
from more severe injury (18). Empirical MRI evidence differ-
entiating early secondary injury processes among TBI seve-
rities, however, has been limited by practical and clinical
challenges hindering the investigation of patients with severe
injury in the first few hours after trauma. In animal studies,
early microstructural and metabolic changes following con-
trolled cortical impact injury indicate that there may be an
optimal temporal window (within the first 4 h) for interven-
tions that could limit secondary damage (12). In humans,
metabolite abnormalities provide correlates of injury severity
and long-term clinical outcome (1,2,13). However, the critical
time window of biochemical disruption underpinning the
development of DAI has not yet been defined. Animal studies
using LFP techniques have highlighted the application of
diffusion-weighted imaging in investigating microstructural
injury and its correlation with cellular level alterations (6).
Recently, through the emergence of dedicated acute brain
injury MRI centres, equipped to image severely injured intu-
bated and ventilated patients, it has become possible to study
pathophysiological changes occurring in the immediate after-
math of severe human TBI.
The grey-white matter junction and midline brain struc-
tures have been reported as particularly vulnerable in TBI.
The corpus callosum (CC), a white matter tract critical for
interhemispheric communication, is reported to be frequently
impacted (20,21) and CC damage could offer an anatomical
imaging correlate of injury severity (22). Injury to the poster-
ior cingulate cortex (PCC), a highly anatomically connected
region forming part of the posterior medial cortex (23), has
also been shown to predict outcome following TBI (24,25).
The PCC plays an important role in health and disease, and
abnormal function following TBI is thought to result in atten-
tional deficits (26). The PCC is bounded superiorly by the
marginal ramus of the cingulate sulcus, posteriorly by the
parieto-occipital sulcus, anteriorly by Brodmann area 24 and
inferiorly by the corpus callosum (26). The cingulum bundle
(CB) provides structural connection between the PCC, the
medial temporal lobes and the ventromedial prefrontal cortex
(27). Damage to functional networks that converge on mid-
line areas vulnerable to TBI are thought to be associated with
persistent post-traumatic complaints (28). Alterations in ima-
ging parameters within inter-related cortical and white matter
regions susceptible to injury may, therefore, shed light on the
metabolic disruption that underpins DAI. To the best of our
knowledge, the relationship between metabolic disruption in
cortical regions and injury of white matter tracts that link
them at a network level has not been investigated, in humans,
in the first 24 h following TBI.
Diffusion-weighted imaging provides the primary method
to non-invasively detect and characterize axonal injury in the
living human brain (29–31). Diffusion tensor imaging (DTI)
maps the directionality and rate of diffusion of water mole-
cules within tissue. The basis and considerations surrounding
DTI have been extensively reviewed (32). For every imaged
voxel in the brain, DTI can provide a range of tissue micro-
structure estimates. Fractional anisotropy (FA) quantifies the
fraction of diffusion that is anisotropic and provides informa-
tion about local fibre coherence. Mean diffusivity (MD) is
used to quantitatively assess the magnitude of diffusion inde-
pendent of direction and is considered to be an inverse
measure of membrane density. Axial diffusivity (AD) repre-
sents diffusivity along the principal axis and, in white matter
tracts, is considered to be parallel to axonal fibres. Radial
diffusivity (RD) is the apparent water diffusion coefficient in
the directions perpendicular to the fibres (33). These mea-
sures reflect the cellular environment and have been shown to
be sensitive indicators of axonal injury in TBI (34).
FA has been shown to decrease (35) and MD increase in
patients with TBI imaged in the subacute to chronic phase
following injury (36–38). But there is a paucity of information
surrounding axonal injury in the hyper-acute phase (<24 h) in
human TBI. Animal studies of severe TBI using DTI and
histological analysis have revealed a temporal pattern of var-
iation in diffusion parameters providing insight into the
underlying pathologies reflecting varying injury states over
time (39–42). Reduced FA, AD and MD provided evidence
of axonal damage within 24 h of injury, confirmed histologi-
cally with further evidence of reactive gliosis by 4 days. After
a week macrophage infiltration, demyelination and edema
was associated with elevated RD, AD and MD and decreased
FA (41). Although the timing of injury progression has been
demonstrated in animal models (43), in humans the equiva-
lent temporal cascade remains unclear.
Here, we set out to characterize the time frame of cortical
and white matter injury progression across the hyper-acute
and acute phases in patients with TBI. We acquired MRSI and
DTI in patients with TBI and age-matched healthy controls to
test the following two hypotheses. Firstly, that metabolic dis-
ruption in the posterior cingulate cortex, and white matter
injury to the corpus callosum and cingulum bundle, are
detectable within the first few hours of trauma and progress
during the first week. Secondly, on the assumption that the
metabolic disruption represents the diffuse secondary cascade
which contributes to the evolution of DAI, we hypothesized
that metabolic disruption and microstructural injury pro-
cesses are correlated with each other and reflect initial severity
and clinical outcome at 1 week.
Methods
Participants
Eighteen adults with a range in severity of TBI (mean age: 48
years, range: 23–83, 13 men, 5 women) were recruited prospec-
tively from the Emergency Department of the Oxford University
Hospitals NHS Foundation Trust (Table 1). All patients received
a CT scan as part of the standard trauma imaging protocol
(according to the NICE head injury guidelines (44)). Once life-
threatening injuries were ruled out, patients were recruited for the
2 T. P. LAWRENCE ET AL.
study. Exclusion criteria included contraindications toMRI, other
injuries leading to instability that would compromise patient
safety in the scanner, and requirement for urgent surgery. MRI
scans were performedwithin 24 h and repeated again at 7–15 days
following injury. In one patient, surgical intervention (fixation)
for an upper limb fracture precluded repeat imaging at 7 days on
safety grounds. The data from this participant were, therefore,
only available from the first time-point. Clinical assessments,
including GCS and neurological examination, were made
throughout the study time period. Initial severity of injury was
assessed using post-resuscitation GCS at presentation. Severity at
one week/short term outcome was assessed using GCS at 7 days
post injury. Patients with a GCS of 12 or less were considered
moderate-severe. Patients with a GCS≥13 were considered mild.
All patients with a GCS 12 or less and/or still in hospital (due to
the TBI) at 7 days were considered moderate-severe at this point.
Eighteen healthy controls age matched to the TBI group (mean
age 41, range: 24–76, independent samples t-test t = −1.34, p =
0.19, 11 women, with no neurological or psychiatric history, nor
any history of significant head injury) were also recruited. None of
the participants received anti-coagulants, blood transfusions or
clotting factors during the study period.
All patients with capacity at the time of initial recruitment
gave written informed consent. For patients lacking capacity,
the lead clinician, in consultation with the family, signed
a declaration form to confirm agreement for the patient to
be recruited into the study. Capacity was assessed by the lead
clinician caring for the patient. Patients with a GCS of 15 who
were orientated in time and place were deemed to have
capacity if it was felt they had the ability to use and under-
stand information to make a decision regarding involvement
in the study, and communicate any decision made.
Explicit patient consent was sought as soon as possible
upon recovery. Healthy controls provided informed written
consent. The study was approved by the South Central –
Berkshire Research Ethics Committee.
MRI data acquisition
All imaging data were acquired on a 3T Siemens Magnetom
Verio scanner at the Oxford Acute Vascular Imaging Centre
(AVIC). The scanning protocol included T1-weighted
MPRAGE, T2-weighted Turbo spin echo and T2* susceptibil-
ity weighted structural imaging (SWI) sequences, 2D proton
magnetic resonance spectroscopic (MRS) chemical shift ima-
ging (CSI) and diffusion-weighted imaging. SWI findings for
a subset of this study population have been reported pre-
viously (45). Single-slab multi-voxel MRSI data were acquired
using a point-resolved spectroscopy (PRESS) sequence using
the following parameters: TR = 1700 ms, TE = 135 ms. Six
saturation bands were applied (40 mm superior and inferior,
50 mm anterior, posterior, right and left lateral). A single
image slab of 160mm3 x 160mm3 x 15mm3 was placed,
according to atlas identified anatomical landmarks, to include
the posterior cingulate cortex superior and posterior to the
splenium of the corpus callosum (Figure 1). This MRSI slab
consisted of a 160 mm x 160 mm grid containing 256 voxels
each with a resolution of 10mm3 x 10mm3 x 15mm3. The
cortical site of injury never extended into the MRS voxels used
in the analysis (the location of the posterior cingulate cortex).
Diffusion-weighted images were acquired along 64 diffusion
directions at a b-value of 1500/mm2 with 5 additional b = 0
measures, using a voxel size of 2 × 2 x 2 mm, TR = 2153 ms,
Table 1. Patient demographics.
Patient Age Gender
Initial
GCS
GCS at
scan 2 Intracranial injuries Extracranial injuries
Time to
scan 1
(hours)
Time to
scan 2
(days)
Discharged
from
hospital by 1
week
1 36 Male 7 15 IVH (seizure) Pneumothorax, scalp haematoma 21 8 days Yes
2 83 Male 6 Intubated
and
sedated
ASDH - 3 7 days No
3 22 Male 14 15 - - 12 7 days Yes
4 42 Male 14 15 - - 18 7 days Yes
5 70 Female 15 15 - - 3 15 days Yes
6 44 Male 8 15 (seizure) - 15 9 days No
7 51 Male 15 15 - - 3.5 7 days Yes
8 30 Male 14 15 - - 5 X Yes
9 61 Female 15 15 EDH - 21 7 days Yes
10 42 Female 14 15 - - 3.5 7 days Yes
11 25 Female 15 15 - - 4 7 days Yes
12 30 Male 14 15 - - 15 7 days Yes
13 52 Female 3 15 IVH, TSAH, ASDH - 6 7 days Yes
14 41 Male 14–8 Intubated
and
sedated
Frontal and temporal
contusions
Rib fractures, cervical and thoracic spinal fractures,
wrist fracture
6 11 days No
15 62 Male 12 15 - Facial fractures 3.5 7 days Yes
16 55 Male 12 15 - Facial abrasions, lacerations and fractures 6.5 14 days Yes
17 72 Male 3 Intubated
and
sedated
Multiple bilateral contusions,
TSAH, pneumocephalus,
petechial haemorrhages
Shoulder abrasions, skull base fractures, facial
fractures
5.5 12 days No
18 48 Male 10 Intubated
and
sedated
TSAH, contusions, petechial
haemorrhages,
Cervical fracture, eye injury, wrist clavicle and rib
fractures, extensive skull fractures frontal sinus and
orbit fractures, skull base fracture
5 12 days No
GCS = Glasgow Coma Scale, IVH = intraventricular haemorrhage, ASDH = acute subdural haematoma, EDH = extradural haematoma, TSAH = traumatic subarachnoid
haemorrhage.
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TE = 85 ms. A simultaneous multi-slice acquisition protocol
(multiband factor 2) (46) was used to acquire two full diffu-
sion data acquisitions in opposing phase-encode directions
(Anterior–Posterior and Posterior–Anterior, for the purpose
of image distortion correction, described below).
Image processing – magnetic resonance spectroscopy
TheMRSI slab was reconstructed in each subject’s native space by
linearly registering the acquired MRSI slab to the participant’s T1
scan. Although efforts were made to place the MRSI slab in
a matching location for all subjects, the exact slab location natu-
rally varied due to each participant’s head position in the scanner
and anatomical variation between participants (Figure 1). No
traumatic lesions, visible on structural imaging, were seen within
the posterior cingulate cortex. Two factors with high bearing on
the reliability of metabolite interpretations are; consistency in the
anatomical area measured across participants, and the reliability
of metabolite concentrations as determined by Cramer Rau Lower
bounds (CRLB). In order tomaximize consistency in the cingulate
Figure 1. 2D CSI slab and example spectra.
(a) T1 from a representative subject showing the position of the 2D CSI slab. b) Overlap map showing posterior cingulate cortex voxels selected for analysis from the
2D CSI slab for each subject overlaid onto the Montreal Neurological Institute (MNI) template brain. (c) A representative spectrum from a healthy control displaying
peaks for total choline (tCho), total creatine (tCr), glutamate and glutamine combined (GLX) and total N-acetyl aspartate (tNAA). No traumatic lesions, visible on
structural imaging, were seen within the posterior cingulate cortex.
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cortex area sampled between subjects, and for longitudinal com-
parison within subjects, we identified a common ‘core’ subset of
voxels for analysis. The selected voxels provided the highest degree
of anatomical consistency between participants and the highest
quality spectral data. First, we excluded all peripheral voxels in the
MRSI slabs, which were located within the saturation bands. From
the remaining central core of each participant’s MRSI slab, two
voxels were selected based firstly on anatomical location (imme-
diately posterior and superior to the splenium of the corpus
callosum) and secondly, on spectral quality (CRLB values >25%
were discarded).
Metabolite concentration ratios were used relative to total
creatine (tCr) (creatine + phosphocreatine). Ratios were gener-
ated from total (t) metabolite values of N-acetylaspartate +
N-acetylaspartylglutmate (NAA + NAAG = tNAA), phospho-
choline + glycerophosphocholine (PCho + GPC = tCho) and
Glutamate + Glutamine (GLX). tNAA/tCr, tCho/tCr, and Glx/
tCr, were estimated using LCModel software (http://www.s-pro
vencher.com/pages/lcmodel.shtml). Voxels withmetabolite con-
centration standard deviations (CRLB) >25% were considered
not reliable and were not selected for analysis. Based on this
criteria, one patient with TBI and two healthy controls were
excluded from metabolite analyses. Metabolite concentrations
were expressed as ratios relative to tCr to control for between-
voxel variation in absolute concentrations. The ratio values were
multiplied by 8 within the LCModel to account for the estimated
concentration of normal tCr, as previously described (47). tCr
absolute concentration did not differ between controls and
patients (independent samples t-test t = −1.12, p = 0.28).
In order to adjust metabolite ratio measurements for the
amount of grey matter within the selected voxels, voxel-wise
grey matter probability values were calculated from each
participant’s T1-weighted anatomical scan using FMRIB’s
Automated Segmentation Tool (FAST) (48). Following seg-
mentation into grey matter, white matter and cerebrospinal
fluid (CSF) tissue types, FAST calculates a partial volume
estimate (PVE) for each voxel providing the best estimate of
the proportion of grey matter in that voxel. These PVE values,
averaged across both voxels, were included in our metabolite-
based statistical analyses as covariates.
Image processing – diffusion tensor imaging
DTI data were pre-processed using FSL tools (49) (https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/FDT/UserGuide). Image distortions
associated with magnetic field inhomogeneities in echo-planar
imaging sequences were corrected using the tool ‘topup’ (50).
Data were collected with reversed phase encode blips to estimate
the susceptibility induced field based on the five non-diffusion
weighted images acquired during the anterior-to-posterior and the
posterior-to-anterior phase encode acquisitions. From these pairs
of images, with distortions going in opposite directions, the sus-
ceptibility induced off-resonance field was estimated (49,51). The
resulting fieldmap was fed into the tool ‘eddy’ to simultaneously
correct the diffusion-weighted images for susceptibility-induced
distortions, eddy current-induced distortions and headmovement
(50). Finally, diffusion tensorswere fit to the data in order to derive
fractional anisotropy (FA),mean diffusivity (MD), axial diffusivity
(AD), lambda 2 and lambda 3 (λ2 and λ3) maps. The mean of λ2
and λ3 was calculated to generate radial diffusivity (RD).
Voxel-wise analyses of diffusion parameters (FA, AD, RD
and MD) were performed using Tract-Based Spatial Statistics
(TBSS) (52). This well-validated technique permits voxel-wise
comparison of diffusion metrics by generating, through non-
linear registration to a standard FA template, a white matter
“skeleton” that represents the core white matter within a study
population, and then sampling individual-subject diffusion
parameters onto this skeleton for statistical analysis (52).
In this way, TBSS attempts to overcome difficulties both in
aligning white matter across subjects and with spatial smooth-
ing, resulting in improved sensitivity, objectivity and inter-
pretability of analysis of multi-participant studies (49,52,53).
The TBSS-derived skeleton was thresholded at 0.3 before
FA, AD, RD and MD values for individual participants were
projected onto the skeleton. In order to restrict our statistical
analyses to voxels within the cingulum bundle (CB) and
corpus callosum (CC), these two regions of interest were
extracted from the probabilistic Harvard-Oxford parcellation
atlas, formed from manual segmentation of the T1-weighted
images acquired from 37 healthy volunteers performed by the
MGH Centre for Morphometric Analysis. The atlas-derived
masks were thresholded in order to retain only those voxels
common to at least 95% of the atlas population to minimize
co-inclusion of neighbouring structures.
Longitudinal TBSS analysis
Three TBSS analyses were performed to assess; a) microstructural
tissue properties in the corpus callosum in patients comparedwith
controls at time point 1 (within 24 h) and again at time point 2
(7–15 days after injury), b) evidence of evolution of injury
between time point 1 and 2 within patients, and c)
a relationship between metabolite ratios in the posterior cingulate
cortex and the diffusion parameters along the corpus callosum +
cingulum bundles. To test for evolution in diffusion parameters
between scan 1 and scan 2, a longitudinal TBSS method was used
to minimize potential registration biases between data acquired at
different time points. In this longitudinal approach (previously
detailed (54)), the difference in FA between time point 1 and time
point 2 was analysed, using a population-optimized skeleton. In
brief, we used the FSL tool SIENA, applied to the non-diffusion
weighted reference images for each patient to generate a halfway
space between the images acquired during scan 1 and scan 2 (55).
The FA maps for scan 1 and scan 2 were subsequently registered
into halfway space for each participant using the transformation
matrices generated by SIENA and then averaged (by summing the
maps together and dividing by 2). An optimized study-specific
skeleton was generated, based on the newly-created averaged FA
maps, in order to reduce possible registration (and parameter
sampling) biases that might arise if the skeleton was created
based only on the images of scan 1 or of scan 2. Next, we created
individual-subject FA difference maps by subtracting scan 2’s
halfway-space FA map from scan 1’s halfway-space FA map.
Finally, the FA difference values were projected onto the study-
specific skeleton and permutation tests (5000 permutations) were
performed to test for a linear trend over time (i.e. to test for
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a positive (or a negative) deviation from zero in the FA change
between the two visits). The same analyses were repeated for AD,
RD and MD.
Statistical analysis
Statistical analyses were performed using SPSS version 24.
Independent samples t-tests were performed to determine any
differences in age and grey matter probability between controls
and patients. Multivariate analyses of covariance (MANCOVA)
were performed to compare the metabolite ratios i) between the
controls and patients at scan 1 and scan 2 and ii) between patient
severity sub-groups (measured by initial GCS and GCS plus
hospital admission status at 1 week). Paired sample t-tests were
performed to compare metabolite parameters in patients between
scan 1 and scan 2. Both age andGMwere included as covariates of
no interest in the analyses of metabolite concentrations. Voxel-
wise analyses of diffusion-based white matter microstructure
parameters were performed through a 2D implementation of
permutation testing within FSL “randomise”, including age as
a nuisance regressor. Randomize permits permutation-based non-
parametric inference testing within the framework of the general
linear model. Group-wise comparisons (controls versus patients
with TBI) were performed using two-sample unpaired t-tests,
while relationships between metabolite ratios and diffusion para-
meters were identified by including de-meaned metabolite con-
centrations as covariates in the general linear model submitted to
permutation testing. Linear effects of time were assessed using
a single group paired t-test. Threshold-Free Cluster Enhancement
(TFCE) was implemented to identify clusters with p-values less
than 0.05 (family-wise error corrected for multiple comparisons).
Due to the exploratory nature of the study, correlation analyses
were not corrected for multiple comparisons.
Results
Age and grey matter
No significant difference was found in age (t = −1.34, p = 0.19)
and mean posterior cingulate cortex grey matter probability esti-
mates (t = −0.17, p = 0.87) between healthy controls and patients
with TBI.
Metabolite disruption and evolution
No traumatic lesions, identifiable on structural imaging (CT
and MRI T1-weighted) were visible within the anatomical
region of the voxels analysed in the posterior cingulate cortex.
In the hyper-acute phase (within 24 h of injury) the tNAA/
tCr ratio in the posterior cingulate cortex (PCC) was 15%
lower in patients than in healthy controls (F = 11.43, p =
0.002) while the tCho/tCr ratio was 10% higher in patients
compared with controls (F = 10.67, p = 0.003) (Figure 2a and
b). No significant difference in GLX/tCr ratio was seen at this
time. In the acute phase (7–15 days), tNAA/tCr ratio in the
PCC remained lower in patients than in controls (on average
20% lower, F = 8.81, p < 0.001). TCho/tCr ratio remained
elevated in patients compared with controls (on average 23%,
F = 10.47, p = 0.001) (Figure 2a and b). No significant
difference was seen in GLX/tCr ratio at 7 days.
We next compared metabolite concentrations measured at
both visits across all patients with TBI, and within TBI severity
subgroups, to determine the evolution in metabolic disruption
between scan 1 (<24 h) and scan 2 (7–15 days). There was no
significant difference in metabolite ratios across all patients when
considered as a single group. However, distinct patterns of evolu-
tion in metabolite disruption emerged when patients were sub-
divided according to injury severity. Although no significant
changes in metabolite concentrations were observed in the mild
Figure 2. Metabolite ratios in controls and TBI patients within 24 h of injury and after 7 days.
Scatter plots displaying the metabolite ratios of a) total N-acetyl aspartate (tNAA) to total creatine (tCr) ratio and b) total choline (tCho) to total Cr ratio. a) The tNAA/tCr
ratio was lower in patients compared with controls at both visits (scan 1: F = 11.43 p = 0.002, scan 2: F = 8.81 p < 0.001. b) tCho/tCr ratios were significantly higher in TBI
patients when compared to controls at both scan 1 (F = 10.67 p = 0.003) and scan 2 (F = 10.47 p = 0.001). C = Controls, Pv1 = Patient visit 1, Pv2 = Patient visit 2. **
represents a value for p < 0.001.
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TBI group (n = 6), the moderate-severe group (n = 11) exhibited
an increase in tCho/tCr ratio between 24 h (scan 1) and 7–15 days
(scan 2) following injury (F = 5.54, p = 0.03), although three
patients showed a decrease rather than increase in tCho/tCr
ratio (Figure 3). When assessed at 1 week, these three patients
all had a GCS of 15 and had been discharged home, in contrast to
the other eight patients who either remained in patients with
a GCS <15 or had significant persistent symptoms.
A Spearman’s correlation analysis was performed on the moder-
ate-severe group (n = 11) to further investigate the relationship
between total Cho/total Cr ratio change and clinical progression.
A negative correlation was found. A tCho/tCr ratio increase
between the two scans correlated negatively with a poor GCS at
1 week post injury (r = −0.770, p = 0.006). Sample sizes in each
subgroup are very small and this should be considered when
interpreting the results.
Analysis of metabolites at individual time points also
revealed variation according to severity. At time point 1,
although no significant difference was seen at the whole-
group level in GLX/tCr ratio, GLX/tCr ratios were lower in
the more severely injured (GCS of 3–12) when compared to
the less severely injured (GCS of 13–15) (F = 10.16, p =
0.007). After 7 days, this pattern was no longer present.
Visual inspection of the tCho/tCr ratios at each time point
suggested lower Cho ratios in patients with a mild injury and
higher ratios in patients with a more severe injury, however
this did not reach significance (Figure 2b).
White matter tract injury
To determine whether patients with TBI also show disruption
in white matter microstructure of the corpus callosum and
cingulum bundle, diffusion parameters measured at scan 1
(<24 h) and scan 2 (7–15 days) were compared against diffu-
sion parameters measured in controls (1 scan only). At the
group level, FA was significantly lower in patients compared
with controls in the splenium of the CC within 24 h of injury
(permutation testing, p = 0.029) (Figure 4). At scan 1, no
significant difference was found for AD, RD or MD. At scan
2, both FA and AD were significantly lower in patients com-
pared with controls (p = 0.027 and p = 0.013, respectively)
(Figure 4). No differences were found for RD or MD.
To determine whether diffusion measures evolved between
the hyper-acute and acute phase in our patient cohort, we
performed longitudinal TBSS analyses testing for linear effects
in FA, MD, RD and AD difference over time between scan 1
and scan 2. Longitudinal analyses revealed increases in both
MD and RD between scan 1 and 2 across patients with TBI at
the group level (p = 0.028 and p = 0.043, respectively). No
significant difference was seen for FA or AD using this
method.
To explore whether these differences in microstructural para-
meters were common to all patients, or might differentially reflect
injury severity, we extracted the mean FA, MD, RD and AD from
the respective clusters showing significant between-group
(FA, AD) white-matter changes, and plotted these for the TBI
subgroups for visualization purposes (Figure 4). These summary
values were plotted separately for patients according to severity
assessed either by GCS at presentation or GCS at one week.When
subdivided according to initial GCS, no clear pattern in the
evolution of FA or ADwas apparent between the two time points.
However, when the patients were grouped according to severity
assessed at 1 week, mild and moderate-severely injured appeared
to segregate, with the lowest FA and AD at scan 2 observed in the
Figure 3. Evolution of total choline ratios from scan 1 to scan 2 in TBI patients.
Scatter plots displaying the evolution of total Cho/total Cr ratios in patients between scan 1 (within 24 h) and scan 2 (7–15 days after injury) with mild injuries. There
was no significant fall in tCho/tCr ratio in patients in the mild group. There was a significant increase in the tCho/tCr ratio in the moderate-severe group overall (F =
5.54, p = 0.030). Within this group, three patients experienced a fall in tCho/tCr ratio (patients 1, 13 and 15). Despite being classified as moderate-severe at initial
presentation, these three patients all improved to a GCS of 15 and had been discharged home within 7 days of their injury. Pv1 = Patient visit 1, Pv2 = Patient visit 2.
Within the moderate to severe group, a negative correlation was found between progression of the tCho/tCr ratio and GCS at 1 week (r = −0.77, p = 0.006). The
greater increase in tCho/tCr ratio correlated with a poor GCS at 1 week.
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more severely injured (Figure 4). No statistical comparison of
these subgroups was performed due to the small number of
patients still classified as mild after one week (n = 5).
Finally, we tested for relationships between metabolite ratios
in the PCC and CC microstructural properties in patients at each
scan as well as change over time, and in healthy controls. No
relationships were found between metabolite ratios and diffusion
parameters in the healthy controls. In patients within 24 h of
injury (scan 1), lower FA values in a cluster localized to the body
of the CC were correlated with higher tCho/tCr ratios in the
PCC (p = 0.029) (Figure 5b and c). No significant relationship
was seen between the other metabolites and diffusion parameters
at scan 1. In patients at scan 2 there was a tendency for an
increase in RD in the splenium/body of the CC to reflect an
Figure 4. Evolution of white matter parameters following TBI.
(a) A sagittal image showing a significant cluster representing FA values lower in patients at scan 1 (<24 h) compared with controls in the splenium of the corpus
callosum (p = 0.029). Green represents the corpus callosum part of the mask, red represents the significant cluster. Scatter plot displaying FA (b & c) and AD (d & e)
for voxels in the corpus callosum according to severity measured at initial presentation (b & d) and at 1 week post injury (c & e). Using TBSS FA was found to be
significantly lower in patients at time point 1 compared with controls (p = 0.029) and in patients at time point 2 compared with controls (p = 0.027). Also, using
TBSS AD was significantly lower in patients at time point 2 compared with controls (p = 0.013). AD was not significantly lower at time point 1 (within 24 h of injury)
therefore not plotted. The significant cluster is overlaid on an MNI152 image. C = Controls, Pv2 = Patient visit 2. * represents a value for p < 0.05.
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increase in tCho/tCr ratio (p = 0.06) in the PCC. No relationship
was seen between other metabolites and diffusion parameters at
scan 2. When correlating the change in the microstructural
parameters with the change in metabolite concentrations
among patients, a large change in RD was associated
with a large change in tCho/tCr ratio; in other words, progres-
sion in RD was positively correlated with progression in tCho/
tCr (p = 0.006) (Figure 6).
Discussion
Our understanding of the secondary injury cascade, and progres-
sion of diffuse axonal injury, in the first few hours and days
following TBI, is limited by clinical tools that, currently, are not
able to reveal the underlying pathophysiological processes thought
to take place in injury-susceptible midline brain regions. Beyond
the consequence of the primary injury that occurs on impact, the
secondary metabolic cascade is central to the progression of injury
and DAI. Here we set out to investigate, firstly, whether such
metabolic disruption would be evident in the posterior cingulate
cortex (PCC) within hours of trauma and reflects disruption in
markers of axon coherence in the associated corpus callosum (CC)
and cingulumbundle (CB). Secondly, we characterized progression
in MRI measures of metabolite ratios and white matter micro-
structure from the hyper-acute (<24 h) to acute (7–15 days) phase
after TBI of varying severities.We foundMRS evidence of neuronal
injury and possible membrane turnover in the PCC within 24 h of
trauma across a range of severities. Metabolic disruptions appeared
to progress as the secondary injury cascade evolved between the
hyper-acute (hours) and acute phase (days to weeks). Studies in rats
provide evidence that RD reflects de/dysmyelination (56,57). Here
we identified white matter microstructural damage in the CC
within 24 h of injury, with worsening RD, providing evidence for
de/dysmyelination across the first 7–15 days post-TBI in humans.
Our findings provide indications that the metabolic disturbance
created by the secondary injury cascade creates an environment
where DAI may progress, reflected by diffusion parameters in the
CC.Of clinical interest, bothMRI techniques differentiated patients
according to injury severity, most importantly reflecting clinical
outcome at 1 week.
Progressive posterior cingulate cortex (PCC) metabolite dis-
ruption between the hyper-acute and acute phase of TBI
Previous studies using MRS in patients with TBI have found
reduced NAA in the parietal lobe, motor cortex, prefrontal cortex
and corpus callosum (58–61) in the acute phase (days) and sub-
acute phase (weeks) after injury (62). NAA reduction in the weeks
Figure 5. Relationship between FA and total choline/total creatine ratio.
(a) Significant cluster from voxel-wise correlation analysis showing lower FA values in the body of the corpus callosum correlating with higher tCho/tCr ratio values in
the posterior cingulate cortex measured within 24 h of injury (p = 0.029). For illustrative purposes, scatter plots allow visualization of the relationship between FA
from the significant cluster and the mean tCho/tCr ratios for each patient averaged across the whole cluster and input into SPSS to display the correlation. b) Plotted
with subgroups according to initial injury severity and c) severity assessed at 1 week.
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andmonths following injury appears to reflect long-term outcome
(11,63). Animal studies have provided evidence of reduced NAA
as soon as 1 h following fluid percussion injury, possibly due to
increased NAA utilization in axonal repair processes (64).
Depression and subsequent recovery of NAA were also reported
in animal studies over the first 7 days following injury, thought to
signify recovery (65–67). In humans, the timescale of metabolic
disruption remains largely unknown. Most human studies were
performed more than 3 days post injury and there has been
speculation that metabolic changes might not be apparent in
patients with mild TBI until 3 days post injury (68). Our findings
provide evidence of injury in the PCC, in normal-appearing brain,
as soon as 3.5 h following trauma, characterized by a fall in NAA
and an increase in Cho, which persist through the first 7 days
following injury. This marked reduction in NAA in the hyper-
acute phase, even in patients with mild TBI, suggests early neuro-
nal injury in the PCC greymatter, while increased Cho, which was
evident at this time point and then progressed, suggests the evolu-
tion of cell membrane disruption from the hyper-acute to the
acute phase.
Evidence of injury progression and indication of severity
Between scan 1 and 2, tNAA/tCr remained low at the group
level in our study, with no evidence of differing patterns
according to clinical severity in this time period. The longer-
term consequences of these early aberrations in NAA may
emerge from ongoing follow-up studies incorporating neu-
ropsychological outcome measures.
In contrast, results from studies investigating Cho have
revealed elevated levels in patients post injury (63,69–71)
and a correlation with long-term outcome when measured
at 7 days in both white matter and grey matter (14).
Elevation of Cho following TBI may reflect membrane dis-
ruption associated with shearing or stretch injuries seen in
DAI as a result of astrocytosis or inflammation (14,71,72).
A relationship between choline levels and severity would,
therefore, be expected, and indeed the highest elevations in
Cho were previously reported in the more severely injured
(14). Our data similarly indicate elevated tCho/tCr levels at
both time-points in patients compared with controls and
Figure 6. Relationship between RD and total choline/total creatine ratio.
(a) Significant cluster showing higher RD values in the body of the corpus callosum correlating with higher tCho/tCr ratio values in the posterior cingulate cortex
measured within 24 h of injury. For illustrative purposes, scatter plots allow visualization of the relationship between RD from the significant cluster and the mean
tCho/tCr ratios for each patient (p = 0.006) averaged across the whole cluster and input into SPSS to display the correlation. b) Plotted with subgroups according to
initial injury severity and c) severity assessed at 1 week.
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further provide evidence for greater progression in patients
with more severe injury (compared to mild injury) at scan 2.
In the mild group, visual examination of individual patients
suggested normalization of tCho/tCr ratios in our sample size
within our follow-up period. In contrast, in the moderate-
severe group, there was a significant increase in tCho/tCr
ratios over time, with notable variations at the single-patient
level. In three moderate-severely injured, tCho/tCr levels
remained stable or fell within the first 7–15 days after injury
(declining to normal levels). Retrospective assessment of these
patients revealed that by day 7 they all had a GCS of 15 and
had been discharged home, in contrast to the other 8 patients
who either remained in-patients with a GCS <15 or had
significant persistent symptoms. Although the numbers were
small in the moderate-severe group (n = 11), limiting inter-
pretation, a negative correlation was found between the tCho/
tCr ratio increase and GCS at 1 week. Consequently, we
propose that a progressive elevation in tCho/tCr ratios in
the first week following injury may represent the progression
of secondary brain injury after the first 24 h and offer
a potential index of TBI severity. Small numbers in the sub-
group analysis must be taken into account when interpreting
the data.
Perhaps surprisingly in our study, GLX did not differ
significantly between patients and controls at the group
level. Previous studies suggest glutamate plays a crucial role
in TBI (73). Acute post-traumatic glutamate release is respon-
sible for excitotoxicity leading to neuronal injury, cell death
and dysfunction of surviving neurons (73). Delayed disrup-
tion of excitatory glutamate circuits leads to deficits in cogni-
tive and motor function (73). The pathophysiological
consequence of glutamate excitotoxicity is similar from mild
(43) to severe TBI (74). MRS studies using a controlled cor-
tical impact model in mice demonstrate decrease in glutamate
at 2 and 4 h after injury (12) and increase in pericontusional
glutamine (75) with variability in the respective progression of
glutamate and glutamine over subsequent days.
We did not find a significant difference in GLX/tCr ratios
between controls and patients at either time points. While
patients with moderate-severe injury showed low GLX/tCr
ratios at scan 1 (within 24 h of injury), there were no longer
any differences between severity subgroups at scan 2 (7–15
days). A pattern in GLX/tCr ratio was seen regarding severity
at the first scan, with low ratios in moderate-severely injured,
but not at the second scan, possibly reflecting normalization
at 1 week. We speculate that reduced GLX/tCr ratios may
reflect early glutamate reduction associated with diffuse injury
in the moderate-severe group with apparent normalization
occurring due to development of increase glutamine asso-
ciated with contusions in these patients.
Diffusion evidence of progressive corpus callosum (CC)
injury
The posterior cingulate cortex (PCC) sits adjacent to, and has
efferent connections with (76), the splenium of the corpus
callosum (CC) which is frequently impacted in trauma
(20,21). The cingulum bundle (CB) provides structural con-
nection between the PCC with the medial temporal lobes and
the ventromedial prefrontal cortex (27). Although we used
a mask of the CB and CC, significant disruption to diffusion
parameters was only found in the CC. Imaging evidence of
disruption in the CC offers a sensitive correlate of injury
severity (22). The relationship between injury in the PCC
and white matter tract injury in the CC in the hyper-acute
phase may provide important insight into the diffuse meta-
bolic environment that predisposes patients to the progression
of diffuse axonal injury (DAI). No studies, to our knowledge,
have investigated longitudinally the relationship between dif-
fusion parameters, measured from the hyper-acute phase to
the acute phase, and PCC metabolic injury. Few studies have
investigated axonal injury in the hyper-acute phase, and all
were conducted either in patients with mild injury or beyond
24 h of injury. Over a longer time period, FA has been shown
to decrease and MD increase in patients with severe TBI
imaged in the subacute (weeks) to chronic (months) phase
following injury (36). Conversely, animal studies of severe TBI
using a cortical impact model with DTI and histological
analysis have revealed a temporal pattern of variation in
diffusion parameters on a much more immediate timescale
following injury (41). A lateral fluid percussion model has also
been used to provide evidence supporting the use of DTI in
the detection of microstructural changes and how these cor-
relate with injury at a cellular level (6). Histological evidence
in mice of axonal injury within 24 h correlated with reduced
FA, AD and MD, while reactive gliosis detected at 4 days and
macrophage infiltration, demyelination and edema after 1
week were associated with elevated RD, AD and MD along-
side decreased FA (41). In our study of diffusion changes in
the hyper-acute phase following human TBI, we found
reduced FA in patients compared with controls within 24
h of injury, which remained low at 7–15 days. While these
results indicate reduced white matter microstructural coher-
ence early after trauma, FA is not a specific marker of any
individual injury process and did not provide a sensitive
marker of injury progression over the first 15 days in our
TBI population.
Conversely, we observed a reduction in AD in patients who
had suffered TBI compared with controls, specifically at scan
2 (7–15 days after trauma). AD is a measure of diffusivity
parallel to the axonal fibres, and a reduction likely reflects
damage and degeneration of the axonal fibres (77,78). Axonal
integrity would be expected to vary by injury severity (as the
degree of axonal disruption may vary) (33,57). However,
when we compared patients according to their initial severity
at presentation, we found no difference in AD between mild
and moderate-severe TBI. When instead, patients were com-
pared according to their status at 7 days, patients with TBI
who had a GCS of 14 or less, or experienced persistent
symptoms, had significantly lower AD than patients who
had been discharged home, had a GCS of 15, with no persis-
tent symptoms. Subdivision of the patient group according to
severity measured at initial presentation revealed no signifi-
cant difference between mild and moderate-severe injury at
either scan. However, when the severity was measured again
at 7 days, according to GCS, a distinction could be seen in
the AD between the two severity groups. AD may, therefore,
offer a sensitive marker of injury severity when early clinical
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and radiological assessment fail to accurately predict short-
term outcome. AD could alternatively reflect injury progres-
sion and act as a marker of the developing secondary injury
cascade. The lack of a significant fall in AD at the first scan
may reflect a more prolonged period of injury progression.
Imaging multiple times every day would be required to under-
stand the optimal period for intervention that might limit the
secondary injury cascade.
Vasogenic oedema and potentially demyelination affect
white matter following TBI. Radial diffusivity is thought to
reflect diffusion of water perpendicular to white matter fibres
(79) which increases in response to both demyelination (56)
and dysmyelination (57). MD describes the per voxel average
magnitude of water diffusion regardless of diffusion direction
(37). Vasogenic oedema following TBI is thought to result in
decreased FA and increased MD and RD (37). In our TBI
group, RD and MD both increased significantly between the
two scans at 24 h and 7–15 days, providing evidence of injury
progression but also more specifically of possible demyelina-
tion and axonal degeneration. RD has been shown to increase
in white matter in the context of pathology and may provide
evidence of axonal degeneration and demyelination (80).
Therefore, the combination of FA, as an early marker of
injury, and RD and MD, providing evidence of oedema or
injury progression, may be important in characterizing devel-
opment and evolution of DAI within the first days and weeks
after injury.
Relationship between injury in the posterior cingulate
cortex (PCC) and the corpus callosum (CC)
Examining the relationship between our observed abnormalities
in metabolite ratios and in microstructural tissue properties fol-
lowing TBI, we firstly found that high tCho/tCr ratios in the PCC
were associated with low FA in the CC as early as 24 h following
TBI. At 7–15 days, there was a tendency for increased RD values
to mirror elevations in tCho/tCr ratios. As previously mentioned,
elevated Cho provides evidence of membrane damage and/or
repair following TBI (13,15). The relationship of FA and RD
with tCho/tCr, at the two different time points, respectively,
suggests early evidence of injury to the PCC and consequent
downstream injury to the CC. The grey matter injury and white
matter disruption may be linked due to anatomical connection or
by being subject to global injury that we see represented in the
PCC, the effects of which manifest in the CC with diffuse axonal
injury. It is possible that the tCho/tCr elevation in the PCC
precedes the RD increase. We could speculate that the tCho/tCr
elevation signifies membrane disruption in the midline structures
and offers amechanism for axonal degeneration/demyelination in
the CC that emerged over the first 7–15 days following trauma.
Longitudinal assessment of diffusion parameters in the CC over
weeks to months could improve our understanding. Nonetheless,
our observed relationship between metabolic disruption and
white matter injury in separate but related anatomical regions,
within the normal-appearing brain on conventional imaging,
suggest that metabolic disruption that takes place in the context
of diffuse axonal injury may provide information about the like-
lihood of secondary injury progression.
Limitations
Limitations exist with this study. Wide heterogeneity exists in
our cohort including age, injury type, initial severity and
outcome. While there are benefits to assessing a range of
injury severities, the lack of homogeneity in other areas raises
some challenges regarding interpretation of results. In addi-
tion, due to the challenges associated with scanning intubated,
ventilated, severely injured patients, in the first few hours after
trauma, the sample size was limited. Greater patient numbers
are needed to replicate our findings and better understand the
relationship between metabolite and diffusion parameter var-
iation and progression of the pathophysiological secondary
injury cascade. Larger cohorts for further subgroup analysis
of mild, moderate and severe TBI are needed to further
explore the potential for MRI as a tool to provide markers
of severity in the hyper-acute phase. In our study, we were
limited by the time intervals between scans. More frequent
scanning sessions within the first 7 days would provide
a more detailed understanding of the temporal window for
evolution of the secondary injury cascade. While these limita-
tions lead to the potential for variable interpretation of the
results, our study does highlight the utility of MRS and DTI to
assess injury severity and progression of the secondary injury
cascade from the first few hours following trauma across all
severities.
In conclusion, in this longitudinal study of patients who
had suffered TBI of all severities, we identified evidence of
metabolic injury and white matter tract injury within 24 h of
trauma. We found evidence of prolonged membrane disrup-
tion in the PCC and progression of DAI in the CC, beyond
the first 24 h, with metabolite ratios acting as potential mar-
kers of worsening severity. In addition, diffusion parameters
seem to provide a more accurate prediction of a patient’s
short-term outcome than conventional assessment with initial
GCS. To our knowledge, a relationship between metabolite
ratios in the PCC and diffusion parameters in the CC has not
been shown before in the hyper-acute phase, and suggests
a link between damage to the PCC and the CC, specifically
the splenium, which may characterize the progression of DAI
and potentially development of damage to functional net-
works. The vital next step will be to identify a relationship
between markers of injury in the PCC and CC in the hyper-
acute phase, and long-term clinical and neuropsychological
outcome. Additionally, further investigation of the functional
networks, thought to underpin cognitive deficits following
TBI, may provide evidence of the link between early metabolic
disruption in the PCC and long-term clinical outcome.
Identifying the biochemical disruption that underpins the
development of DAI, in the time frame that corresponds with
progression of the secondary injury cascade (yet to be defined
in humans), may create the opportunity to implement treat-
ment to prevent its progression.
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